Mark Tarr Biography and Net Worth

CEO of Encompass Health

Mark Tarr has served as President and Chief Executive Officer for Encompass Health since Dec. 29, 2016. Prior to assuming the role of President and Chief Executive Officer, Tarr served as executive vice president and chief operating officer for Encompass Health from 2011-2016, having served as executive vice president of operations since Aug. 1, 2007, and as president of the company’s inpatient division since September 2004. He joined Encompass Health in 1993, and has held various management positions within the company. Tarr earned his bachelor’s degree from Ball State University and his master’s in business administration from the Goizueta Business School at Emory University.

What is Mark J. Tarr's net worth?: The estimated net worth of Mark J. Tarr is at least $54.80 million as of April 30th, 2024. Mr. Tarr owns 554,098 shares of Encompass Health stock worth more than $54,800,292 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Tarr may own. Additionally, Mr. Tarr receives a salary of $3,430,000.00 as CEO at Encompass Health. Learn More about Mark J. Tarr's net worth.
How old is Mark J. Tarr?: Mr. Tarr is currently 62 years old. There are 4 older executives and no younger executives at Encompass Health. Learn More on Mark J. Tarr's age.
What is Mark J. Tarr's salary?: As the CEO of Encompass Health Co., Mr. Tarr earns $3,430,000.00 per year. Learn More on Mark J. Tarr's salary.
How do I contact Mark J. Tarr?: The corporate mailing address for Mr. Tarr and other Encompass Health executives is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. Encompass Health can also be reached via phone at (205) 967-7116 and via email at [email protected]. Learn More on Mark J. Tarr's contact information.
Has Mark J. Tarr been buying or selling shares of Encompass Health?: Mark J. Tarr has not been actively trading shares of Encompass Health within the last three months. Most recently, Mark J. Tarr sold 44,976 shares of the business's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a transaction totalling $3,745,151.52. Following the completion of the sale, the chief executive officer now directly owns 554,098 shares of the company's stock, valued at $46,139,740.46. Learn More on Mark J. Tarr's trading history.
Who are Encompass Health's active insiders?: Encompass Health's insider roster includes Greg Carmichael (Director), Elissa Charbonneau (Insider), Douglas Coltharp (CFO), John Darby (EVP,General Counsel & Corporate Secretary), Kevin O'Connor (Director), Andrew Price (CAO), Mark Tarr (CEO), and Terrance Williams (Director). Learn More on Encompass Health's active insiders.
Are insiders buying or selling shares of Encompass Health?: In the last year, Encompass Health insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $167,460.00. In the last year, insiders at the sold shares 4 times. They sold a total of 81,779 shares worth more than $6,874,619.34. The most recent insider tranaction occured on August, 13th when CFO Douglas E Coltharp sold 12,260 shares worth more than $1,058,528.40. Insiders at Encompass Health own 2.1% of the company. Learn More about insider trades at Encompass Health.
Information on this page was last updated on 8/13/2024.

Mark J. Tarr Insider Trading History at Encompass Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/30/2024	Sell	44,976	$83.27	$3,745,151.52	554,098
8/16/2023	Sell	25,330	$71.06	$1,799,949.80	497,405
8/17/2022	Sell	20,449	$53.25	$1,088,909.25	440,895
5/14/2020	Sell	26,132	$61.92	$1,618,093.44	409,197
5/1/2019	Sell	67,382	$63.56	$4,282,799.92
5/1/2018	Sell	33,100	$60.96	$2,017,776.00
8/7/2017	Sell	22,625	$43.00	$972,875.00	283,134
8/3/2017	Sell	22,625	$42.55	$962,693.75	283,134
11/9/2016	Buy	6,371	$39.29	$250,316.59	238,890
8/2/2016	Sell	20,000	$41.85	$837,000.00	252,519
2/27/2015	Sell	11,000	$43.82	$482,020.00

Mark J. Tarr Buying and Selling Activity at Encompass Health

Encompass Health Company Overview

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Today's Range

Now: $98.90

$98.29

$99.58

50 Day Range

MA: $96.83

$91.31

$103.53

2 Week Range

Now: $98.90

$63.78

$104.55

Volume

678,090 shs

Average Volume

641,374 shs

Market Capitalization

$9.96 billion

P/E Ratio

23.89

Dividend Yield

0.67%

Beta

0.88

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

Mark Tarr Biography and Net Worth

What is Mark J. Tarr's net worth?

How old is Mark J. Tarr?

What is Mark J. Tarr's salary?

How do I contact Mark J. Tarr?

Has Mark J. Tarr been buying or selling shares of Encompass Health?

Who are Encompass Health's active insiders?

Are insiders buying or selling shares of Encompass Health?